<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://www.fiercebiotech.com" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>John C. Martin</title>
 <link>http://www.fiercebiotech.com/tags/john-c-martin-0</link>
 <description></description>
 <language>en</language>
<item>
 <title>Gilead CEO John C. Martin - CEO pay report</title>
 <link>http://www.fiercebiotech.com/special-reports/gilead-ceo-john-c-martin-ceo-pay-report?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FB0</link>
 <description>&lt;p&gt;&lt;img src=&quot;http://static.fiercemarkets.com/public/newsletter/fiercebiotech/martin.jpg&quot; alt=&quot;John C. Martin&quot; align=&quot;right&quot; /&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;&lt;u&gt;John C. Martin - Gilead&lt;/u&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Total Compensation: &lt;/strong&gt;$10.8 million&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Details: &lt;/strong&gt;Martin received roughly $1 million in salary, $1.6 million in bonuses and $3,800 in &quot;other&quot; compensation. Most of Martin&#039;s slary came from stock and option awards valued at about $10.1 million. Overall, Martin&#039;s compensation fell 6.8 percent from 2006.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Gilead News:&lt;/strong&gt;&lt;br /&gt;&lt;a href=&quot;http://www.fiercebiotech.com/story/gilead-shares-surge-on-letairis-approval/2007-06-18&quot;&gt;&lt;span style=&quot;color: #0c4790&quot;&gt;FDA approves Letairis&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;a href=&quot;http://www.fiercebiotech.com/story/gilead-touts-phase-iii-hep-b-results/2007-06-25&quot;&gt;Gilead touts Phase III Hep B results&lt;/a&gt;&lt;/p&gt;</description>
 <comments>http://www.fiercebiotech.com/special-reports/gilead-ceo-john-c-martin-ceo-pay-report#comments</comments>
 <category domain="http://www.fiercebiotech.com/tags/ceo-pay">CEO pay</category>
 <category domain="http://www.fiercebiotech.com/tags/gilead-0">Gilead</category>
 <category domain="http://www.fiercebiotech.com/tags/john-c-martin-0">John C. Martin</category>
 <pubDate>Fri, 25 Apr 2008 14:52:55 -0400</pubDate>
 <dc:creator>Maureen Martino</dc:creator>
 <guid isPermaLink="false">24003 at http://www.fiercebiotech.com</guid>
</item>
</channel>
</rss>
